Pathstone Holdings’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $937K | Buy |
6,174
+1,977
| +47% | +$300K | ﹤0.01% | 1428 |
|
|
2025
Q1 | $633K | Buy |
4,197
+441
| +12% | +$66.5K | ﹤0.01% | 1602 |
|
|
2024
Q4 | $693K | Sell |
3,756
-809
| -18% | -$149K | ﹤0.01% | 1569 |
|
|
2024
Q3 | $899K | Buy |
4,565
+48
| +1% | +$9.46K | ﹤0.01% | 1425 |
|
|
2024
Q2 | $933K | Buy |
4,517
+548
| +14% | +$113K | ﹤0.01% | 1371 |
|
|
2024
Q1 | $1.08M | Sell |
3,969
-889
| -18% | -$241K | 0.01% | 1237 |
|
|
2023
Q4 | $1.15M | Buy |
+4,858
| New | +$1.15M | 0.01% | 1001 |
|